Drug Profile
Research programme: sphingosine-1 phosphate receptor agonists - AbbVie
Alternative Names: ABT-363; S1P5 - AbbVie; Sphingosine-1 phosphate receptor 5 agonists - AbbVieLatest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer AbbVie
- Class Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Lysosomal storage diseases